A new trading day began on Friday, with Context Therapeutics Inc (NASDAQ: CNTX) stock price up 10.43% from the previous day of trading, before settling in for the closing price of $1.15. CNTX’s price has ranged from $0.49 to $1.55 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 4.72% over the past five years. Meanwhile, its annual earnings per share averaged 24.18%. With a float of $61.00 million, this company’s outstanding shares have now reached $91.88 million.
Context Therapeutics Inc (CNTX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Context Therapeutics Inc is 33.61%, while institutional ownership is 43.09%. The most recent insider transaction that took place on Jun 09 ’25, was worth 70,080. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $0.70, taking the stock ownership to the 920,190 shares. Before that another transaction happened on Jun 06 ’25, when Company’s Chief Legal Officer, Corp. Sec bought 20,000 for $0.58, making the entire transaction worth $11,520. This insider now owns 29,000 shares in total.
Context Therapeutics Inc (CNTX) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.68% during the next five years compared to 4.72% growth over the previous five years of trading.
Context Therapeutics Inc (NASDAQ: CNTX) Trading Performance Indicators
Here are Context Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.28, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Context Therapeutics Inc (CNTX)
Context Therapeutics Inc (NASDAQ: CNTX) saw its 5-day average volume 1.15 million, a positive change from its year-to-date volume of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 73.45%.
During the past 100 days, Context Therapeutics Inc’s (CNTX) raw stochastic average was set at 67.99%, which indicates a significant decrease from 90.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0859 in the past 14 days, which was higher than the 0.0857 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1650, while its 200-day Moving Average is $0.8770. Nevertheless, the first resistance level for the watch stands at $1.3267 in the near term. At $1.3833, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4667. If the price goes on to break the first support level at $1.1867, it is likely to go to the next support level at $1.1033. Assuming the price breaks the second support level, the third support level stands at $1.0467.
Context Therapeutics Inc (NASDAQ: CNTX) Key Stats
With a market capitalization of 116.69 million, the company has a total of 91,879K Shares Outstanding. Currently, annual sales are 0 K while annual income is -26,730 K. The company’s previous quarter sales were 0 K while its latest quarter income was -9,690 K.
